The FDA withdrew the emergency use authorization for AstraZeneca’s Covid antibody cocktail Evusheld because it does not work against omicron subvariant XBB.1.5
FDA pulls authorization for AstraZeneca’s Covid antibody drug Evusheld
You May Also Like
Where will all the laid-off tech workers go?
- February 1, 2023
The path forward for tech workers won’t be easy, but there are options. | David Paul Morris/Bloomberg via…
Trump’s MAGA force swamps the competition in New Hampshire
- December 16, 2023
Ron DeSantis and Nikki Haley’s events pale in comparison to Trump’s raucous Saturday rally, as they continue to…
Capitol rioter who bragged he ‘took the White House’ charged with lying to the FBI
- August 30, 2023
The FBI arrested William Frederick Beals II, of Georgia, who stormed the Capitol on Jan. 6 and bragged…
Biden and Trudeau’s immigration deal makes it easier for both countries to turn away asylum seekers
- March 24, 2023
US President Joe Biden meets with Canadian Prime Minister Justin Trudeau in Mexico City, on January 10, 2023,…
Judge rules against LGBTQ students in Title IX college discrimination suit
- January 14, 2023
A federal judge dismissed on Thursday a lawsuit filed by LGBTQ students who allege the Department of Education…
Blast in central Paris injures multiple people, gas explosion suspected
- June 21, 2023
PARIS, June 21 — A blast ripped through a street in the busy Latin Quarter of central Paris…